http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021182474-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97de133cff1cb61dd37a383958c0374c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
filingDate 2021-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cecc63d5ad3f360cf83fc396e71f55f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be55afae5e36bca7121f008c80d13d65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5460ae60d55ee4cda1cee0d47dcee736
publicationDate 2021-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021182474-A1
titleOfInvention Oligonucleotide and target rna site-specific editing method
abstract A target-editing guide oligonucleotide that introduces site-specific editing to target RNA, said oligonucleotide comprising a first oligonucleotide that identifies the target RNA, a second oligonucleotide that is linked to the 3'-side of the first oligonucleotide, a third oligonucleotide which has a base sequence capable of forming a complementary strand together with the second oligonucleotide, and a first linking group that links the 5' end of the first oligonucleotide and the 3' end of the third oligonucleotide to one another. The first oligonucleotide comprises: a target-corresponding nucleotide residue that corresponds to an adenosine residue in the target RNA; a nucleotide chain comprising at least 10 and no more than 24 residues that is linked to the 5' side of the target-corresponding nucleotide residue and has a base sequence which is complementary to the target RNA; and a nucleotide chain comprising at least 2 and no more than 7 residues that is linked to the 3' side of the target-corresponding nucleotide residue and has a base sequence which is complementary to the target RNA.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023152371-A1
priorityDate 2020-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020246560-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019111957-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021020550-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019093098-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019532644-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5861288-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017010556-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018161032-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961

Total number of triples: 30.